Vietnam Veterans Liver Fluke Cancer Study Act

119 HR 586 EH: Vietnam Veterans Liver Fluke Cancer Study Act U.S. House of Representatives text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS1st Session H. R. 586

IN THE HOUSE OF REPRESENTATIVES AN ACT To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.

1.Short titleThis Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act.

2.Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era (a)Epidemiological studyNot later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall include— (1)an identification of the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and (2)for each of the groups specified in paragraph (1), an identification of the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis. (b)Reports to Congress (1)Initial reportNot later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing— (A)the results of the study under subsection (a); and (B)recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a). (2)Follow-Up reportsThe Secretary shall periodically submit to the Congress a follow-up reports, as determined by the Secretary, to provide updates to the information included in the initial report under paragraph (1) and information collected pursuant to subsection (c). (c)Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam eraThe Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress in follow-up reports submitted under subsection (b)(2). (d)DefinitionsIn this section: (1)The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code. (2)The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era.

3.Extension of certain limitation of pension paymentsSection 5503(d)(7) of title 38, United States Code, is amended by striking November 30, 2031 and inserting December 31, 2031. Passed the House of Representatives April 7, 2025.Kevin F. McCumber,Clerk.

119 HR 586 IH: Vietnam Veterans Liver Fluke Cancer Study Act U.S. House of Representatives 2025-01-21 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I119th CONGRESS1st SessionH. R. 586IN THE HOUSE OF REPRESENTATIVESJanuary 21, 2025Mr. LaLota (for himself, Mr. Ryan, Mr. Fitzpatrick, Mr. Davis of North Carolina, Mr. Gottheimer, and Mr. Ciscomani) introduced the following bill; which was referred to the Committee on Veterans' AffairsA BILLTo direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.

1.Short titleThis Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act.

2.Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era (a)Epidemiological studyNot later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall include— (1)an identification of the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and (2)for each of the groups specified in paragraph (1), an identification of the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis. (b)Reports to Congress (1)Initial reportNot later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing— (A)the results of the study under subsection (a); and (B)recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a). (2)Follow-Up reportsThe Secretary shall periodically submit to the Congress a follow-up reports, as determined by the Secretary, to provide updates to the information included in the initial report under paragraph (1) and information collected pursuant to subsection (c). (c)Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam eraThe Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress in follow-up reports submitted under subsection (b)(2). (d)DefinitionsIn this section: (1)The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code. (2)The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era.

119 HR 586 : Vietnam Veterans Liver Fluke Cancer Study Act U.S. House of Representatives 2025-04-08 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IIB119th CONGRESS1st SessionH. R. 586IN THE SENATE OF THE UNITED STATESApril 8, 2025Received; read twice and referred to the Committee on Veterans' AffairsAN ACTTo direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.1.Short titleThis Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act.2.Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era(a)Epidemiological studyNot later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall include—(1)an identification of the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and(2)for each of the groups specified in paragraph (1), an identification of the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis.(b)Reports to Congress(1)Initial reportNot later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing—(A)the results of the study under subsection (a); and(B)recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a).(2)Follow-Up reportsThe Secretary shall periodically submit to the Congress a follow-up reports, as determined by the Secretary, to provide updates to the information included in the initial report under paragraph (1) and information collected pursuant to subsection (c).(c)Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam eraThe Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress in follow-up reports submitted under subsection (b)(2).(d)DefinitionsIn this section:(1)The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code.(2)The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era.3.Extension of certain limitation of pension paymentsSection 5503(d)(7) of title 38, United States Code, is amended by striking November 30, 2031 and inserting December 31, 2031.Passed the House of Representatives April 7, 2025.Kevin F. McCumber,Clerk.